Neuroimaging: a scanner, colourfully.
Jonathan P. Roiser, Geraint Rees
Current Biology April 10, 2012 DOI: 10.1016/j.cub.2012.02.033 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Intervention | Psilocybin |
| Key points | The abstract reports that psilocybin increased sensory cortex responses during emotional recollection and decreased resting-state blood flow in the prefrontal cortex, changes the authors suggest may have implications for treating depression. |
Abstract
Two recent studies report changes in human brain responses after exposure to psilocybin, the active ingredient of hallucinogenic mushrooms. Psilocybin increased sensory cortex responses during emotional recollection, but decreased resting-state blood flow in prefrontal cortex, with potential implications for treating depression.
Citations in the library
Cited by 3
Cites 6
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology July 19, 2010
- Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin The British Journal of Psychiatry January 27, 2012
- Can psychedelics have a role in psychiatry once again? The British Journal of Psychiatry June 1, 2005
and 1 more in the library